RS

Raju Srinivas Nadimpalli

Active Director Director DIN 11145826
DIN 11145826 First appointment Jun 2025 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Raju Srinivas Nadimpalli

Data last updated:

Raju Srinivas Nadimpalli is a Director at Vikasith Lifesciences Private Limited (since 2025). The company operates in Pharma.

DIN 11145826
Primary Designation Director
Industry Pharma
First Appointment 09 Jun 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director09 Jun 20252025Active

Directorship timeline

Open interactive timeline →
Vikasith Lifesciences Private Limited
Premium access

Shareholding and investment profile for Raju Srinivas Nadimpalli

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Raju Srinivas Nadimpalli

Raju Srinivas Nadimpalli currently holds 1 directorship: Vikasith Lifesciences Private Limited (Director, since 09 Jun 2025).

Raju Srinivas Nadimpalli was first appointed on 09 Jun 2025 as Director at Vikasith Lifesciences Private Limited.

The current boards of Raju Srinivas Nadimpalli's companies include Priyanandana Varma Mudunuri (Vikasith Lifesciences Private Limited), Pullam Raju Ruddaraju (Vikasith Lifesciences Private Limited), Selvakumar Balaraman (Vikasith Lifesciences Private Limited), Vatsavayi Srinivasa Raghava Raju (Vikasith Lifesciences Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available